The Top 15 Biotech Companies to Find in Amsterdam
Known for its nightlife and the beauty of its canals, Amsterdam is also the home…
September 2, 2021 - 7 minutes
Kiadis Pharma
European Cancer Deals Increasingly Focus on Natural Killer Cells
Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene,…
February 23, 2021 - 6 minutes
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
December 17, 2020 - 6 minutes
Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
November 3, 2020 - 3 minutes
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma…
July 13, 2020 - 3 minutes
Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial
The Dutch company Kiadis Pharma has discontinued the development of a cell therapy in blood…
November 13, 2019 - 2 minutes
Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market
The Dutch Kiadis Pharma has raised €27.6M in a private placement to fund the clinical…
June 3, 2019 - 2 minutes
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
Although biotech may seem like an industry that has only just gotten started, it was…
January 23, 2018 - 10 minutes
Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching
Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors…
December 4, 2017 - 2 minutes
Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment
The FDA has backed Kiadis Pharma's lead blood cancer product by granting it the Regenerative Medicine…
September 20, 2017 - 2 minutes
Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer
Arthur Lahr, CEO of Kiadis Pharma, explains the promising cell therapy the company is developing…
May 22, 2017 - 7 minutes
BRIEF: Dutch Biotech Goes for MAA in the EU with new Immunotherapy
Kiadis Pharma has applied for marketing authorization from the EMA for its T cell immune…
April 26, 2017 - 1 minute
